Is Abbott Laboratories overvalued?

Abbott Laboratories (ABT) looks overvalued — trading about 64% above its fair value.

Overvalued

Price

$110.92

Fair value

$40.45

Current P/E

29.8

Normal P/E

10.9

Market cap

$191.93B

Dividend yield

2.3%

Return on equity

10.5%

Sector

Healthcare

Fair value compares ABT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks